Amylx Pharmaceuticals Inc (AMLX) Stock Price Today
Aura AI Summary
Key Stats
- $2.41BMarket Cap
- -Volume
- HealthSector
- $24.1952W High
- $7.8252W Low
- -Typical Hold Time
- $2.16BEnterprise Value
- -Div Yield
- -Trading Activity
Track Amylx Pharmaceuticals Inc (AMLX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amylx Pharmaceuticals Inc has traded between a low of $7.82 and a high of $25, highlighting its annual price range. Buy and sell Amylx Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Most Recent News
Gold breaks out of summer price channel, rallying alongside silver and mining stocks.
Gold has recently broken out of the price channel that had kept it stable since summer, sparking a rally that is also lifting silver and mining stocks. This movement is significant as gold and bonds are highly sensitive indicators of market imbalance...
Google wins $10M auction for Spirit Airlines data to boost AI development
Google has won a $10 million bankruptcy auction for Spirit Airlines' internal business data and software, which includes around 100 million emails and 500 million Microsoft Teams messages. The data will be used to improve Google's products and AI mod...
Babcock & Wilcox rated STRONG BUY on growth from data center power solutions and major contracts.
Babcock & Wilcox (BW) is rated a strong buy due to its strategic position in providing fast, modular power solutions for data centers amid rising demand and grid limitations. The company secured a $2.4 billion Base Electron contract and has a $14 bil...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.